Jeffrey S. Hatfield Insider Trading $NVIV INVIVO THERAPEUTICS HOLDINGS CORP.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jeffrey S. Hatfield.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jeffrey S. Hatfield. Jeffrey S. Hatfield is Director in AMBIT BIOSCIENCES CORP ($AMBI) and Chief Executive Officer in Vitae Pharmaceuticals, Inc ($VTAE) and Director in INVIVO THERAPEUTICS HOLDINGS CORP. ($NVIV) and Director in aTYR PHARMA INC ($LIFE) and Chief Executive Officer in ZAFGEN, INC. ($ZFGN) and Director in MIRAGEN THERAPEUTICS, INC. ($MGEN) and Director in Vir Biotechnology, Inc. ($VIR).

Jeffrey S. Hatfield in INVIVO THERAPEUTICS HOLDINGS CORP.

Trading Symbol: NVIV
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Jeffrey S. Hatfield: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 23 2018
$NVIV Market Capitalization: $139.34M
$NVIV Previous Close: $4.45

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Jeffrey S. Hatfield in INVIVO THERAPEUTICS HOLDINGS CORP.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMBI, LIFE, NVIV, LRMR, VIR, MGEN, VTAE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 23 2018NVIVINVIVO THERAPEUTIC ...Hatfield Jeffrey S.DirectorOption ExerciseA0.6912,5008,62512,500
Nov 03 2016NVIVINVIVO THERAPEUTIC ...Hatfield Jeffrey S.DirectorOption ExerciseA4.2525,000106,25025,000

Page:   1